Tasly Biotech: The company will comprehensively consider factors such as continuous returns to investors and the company's operational development funding needs to determine the profit distribution plan.

NightAirdropper · 2026-03-12T01:43:51+00:00

Tomson Biotech responded on the investor relations platform, stating that the company will consider both investor returns and its funding needs when deciding on profit distribution, with the specific plan subject to publicly available information.

NightAirdropper

2026-03-12 01:43:51

Abstract generation in progress

Securities Star News: Tang Chen Bei Jian (300146) responded to investor questions on the investor relations platform on March 11.

Investor: The company’s performance this year is better than last year. The dividend for 2025 should also be higher than last year. Please convey this to the major shareholders and the board of directors. Thank you.

Tang Chen Bei Jian Secretary: Dear investor! The company will consider factors such as ongoing returns to investors and the company’s operational development needs when determining the profit distribution plan. Please refer to the company’s publicly disclosed information for specifics. Thank you for your suggestion.

The above content is compiled from publicly available information by Securities Star, generated by AI algorithm (Wang Xin Suan Bei 310104345710301240019), and does not constitute investment advice.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.